Sixth Street, KKR to Provide BridgeBio $1 Billion in Preferred Equity

Sixth Street Partners and KKR & Co. have agreed to provide $1 billion of preferred equity to biotechnology company BridgeBio Pharma Inc., according to Bloomberg, citing people with knowledge of the matter.